Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/36284 |
Resumo: | The transition from childhood to adolescence is a period of life characterized by hormonal and physiological changes. In this phase, there are also several social interactions that change according to the environment, imposing responsibilities and a desire for new cycles. These demands make people vulnerable and insecure to certain feelings, generating mood disorders that can progress to major depression disorder. Objective: to evaluate the efficacy and risks of psychotropic drugs prescribed to children and adolescents with depression disorders. Method: This is a bibliographic review of scientific articles of the descriptive-quantitative type, searched online, on Google Scholar platforms, Virtual Health Library - VHL (Medline, IBECS, LILACS), Portal Periodicals CAPES and SciELO and prepared from 1987 to 2021. The search used the descriptors, antidepressants, psychotropic drugs, adverse effects, depressed children and adolescents, in Portuguese, English and Spanish. Result: the same psychotropic drug is used in several other mental disorders, such as bipolar disorder and anxiety. Drugs that demonstrated significant efficacy were Serotonin Reuptake Inhibitors (SSRIs) such as paroxetine, sertraline and fluoxetine. Final Considerations: the psychotropic drugs used to treat depression in children and adolescents, although they are effective in some cases, nevertheless cause several adverse effects. The use of these drugs should not be carried out indiscriminately so that their risks do not outweigh their benefits, and it is essential to assess the causes of childhood depression and the clinical follow-up of patients by a multidisciplinary team. |
id |
UNIFEI_750568216baa99087ca2ba4f08237829 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/36284 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature reviewEficacia y riesgos del uso de psicofármacos en niños y adolescentes con transtornos depressivos: una revisión de la literaturaEficácia e riscos do uso de psicofármacos em crianças e adolescentes com transtornos de depressão: uma revisão bibliográfica AntidepressivosCriançasAdolescentesFatores de risco e suicídio.AntidepresivosNiñosAdolescentesFactores de riesgo y suicidio.AntidepressantsChildrenTeenagersRisk factors and suicide.The transition from childhood to adolescence is a period of life characterized by hormonal and physiological changes. In this phase, there are also several social interactions that change according to the environment, imposing responsibilities and a desire for new cycles. These demands make people vulnerable and insecure to certain feelings, generating mood disorders that can progress to major depression disorder. Objective: to evaluate the efficacy and risks of psychotropic drugs prescribed to children and adolescents with depression disorders. Method: This is a bibliographic review of scientific articles of the descriptive-quantitative type, searched online, on Google Scholar platforms, Virtual Health Library - VHL (Medline, IBECS, LILACS), Portal Periodicals CAPES and SciELO and prepared from 1987 to 2021. The search used the descriptors, antidepressants, psychotropic drugs, adverse effects, depressed children and adolescents, in Portuguese, English and Spanish. Result: the same psychotropic drug is used in several other mental disorders, such as bipolar disorder and anxiety. Drugs that demonstrated significant efficacy were Serotonin Reuptake Inhibitors (SSRIs) such as paroxetine, sertraline and fluoxetine. Final Considerations: the psychotropic drugs used to treat depression in children and adolescents, although they are effective in some cases, nevertheless cause several adverse effects. The use of these drugs should not be carried out indiscriminately so that their risks do not outweigh their benefits, and it is essential to assess the causes of childhood depression and the clinical follow-up of patients by a multidisciplinary team.La transición de la niñez a la adolescencia es un período de la vida caracterizado por cambios hormonales y fisiológicos. En esta fase también hay varias interacciones sociales que cambian según el entorno, imponiendo responsabilidades y ganas de nuevos ciclos. Estas demandas vuelven a las personas vulnerables e inseguras ante ciertos sentimientos, generando trastornos del estado de ánimo que pueden progresar a un trastorno de depresión mayor. Objetivo: evaluar la eficacia y los riesgos de los psicofármacos prescritos a niños y adolescentes con trastornos depresivos. Método: Se trata de una revisión bibliográfica de artículos científicos de tipo descriptivo-cuantitativo, buscados en línea, en plataformas Google Scholar, Biblioteca Virtual en Salud - BVS (Medline, IBECS, LILACS), Portal Periódicos CAPES y SciELO y elaborados desde 1987 hasta 2021. La búsqueda utilizó los descriptores antidepresivos, psicofármacos, efectos adversos, niños y adolescentes deprimidos, en portugués, inglés y español. Resultado: la misma droga psicotrópica se usa en varios otros trastornos mentales, como el trastorno bipolar y la ansiedad. Los fármacos que demostraron una eficacia significativa fueron los inhibidores de la recaptación de serotonina (ISRS), como la paroxetina, la sertralina y la fluoxetina. Consideraciones finales: los psicofármacos utilizados para el tratamiento de la depresión en niños y adolescentes, si bien son efectivos en algunos casos, sin embargo provocan diversos efectos adversos. El uso de estos fármacos no debe realizarse de forma indiscriminada para que sus riesgos no superen a sus beneficios, siendo fundamental la valoración de las causas de la depresión infantil y el seguimiento clínico de los pacientes por un equipo multidisciplinar.A transição da infância para a adolescência é um período da vida caracterizado por mudanças hormonais e fisiológicas. Nessa fase também ocorrem diversas interações sociais que mudam de acordo com o ambiente, impondo responsabilidades e anseio por novos ciclos. Essas exigências tornam as pessoas vulneráveis e inseguras a certos sentimentos, gerando transtornos de humores que podem evoluir para transtorno de depressão maior. Objetivo: avaliar a eficácia e os riscos de psicofármacos prescritos para crianças e adolescentes com transtornos de depressão. Método: Trata-se de uma pesquisa de revisão bibliográfica de artigos científicos do tipo descritivo-quantitativo, pesquisados de forma virtual, nas plataformas do Google Acadêmico, Biblioteca Virtual em Saúde – BVS (Medline, IBECS, LILACS), Portal Periódicos CAPES E SciELO e elaborados no período de 1987 até 2021. Na busca foram usados os descritores, antidepressivos, psicofármacos, efeitos adversos, crianças e adolescentes deprimidos, nos idiomas português, inglês e espanhol. Resultado: o mesmo psicofármaco é utilizado em diversos outros transtornos mentais, como o de bipolaridade e ansiedade. Os medicamentos que demonstraram eficácia significativa foram os Inibidores da Recaptação de Serotonina (ISRS) como a paroxetina, sertralina e fluoxetina. Considerações Finais: os psicofármacos utilizados para tratar a depressão de crianças e adolescentes embora sejam eficazes em alguns casos, entretanto provocam vários efeitos adversos. O uso desses fármacos não deve realizado de forma indiscriminada para que seus riscos não sejam superiores aos seus benefícios, sendo essencial a avaliação das causas da depressão infantil e o acompanhamento clínico dos pacientes por uma equipe multidisciplinar.Research, Society and Development2022-10-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3628410.33448/rsd-v11i14.36284Research, Society and Development; Vol. 11 No. 14; e304111436284Research, Society and Development; Vol. 11 Núm. 14; e304111436284Research, Society and Development; v. 11 n. 14; e3041114362842525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/36284/30363Copyright (c) 2022 Beatriz Botero; Erick Frota Gomes Figueiredo; Jesus Eden Bezerra da Costa; Méllory Nétaly de Oliveira Magalhães; Pablo Henrique Freitas de Almeida ; Salomão Rocha Martim; Ytalo Thiago Praciano da Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBotero, BeatrizFigueiredo, Erick Frota Gomes Costa, Jesus Eden Bezerra da Magalhães, Méllory Nétaly de Oliveira Almeida , Pablo Henrique Freitas de Martim, Salomão Rocha Silva, Ytalo Thiago Praciano da 2022-11-08T13:36:27Zoai:ojs.pkp.sfu.ca:article/36284Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:53.927036Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review Eficacia y riesgos del uso de psicofármacos en niños y adolescentes con transtornos depressivos: una revisión de la literatura Eficácia e riscos do uso de psicofármacos em crianças e adolescentes com transtornos de depressão: uma revisão bibliográfica |
title |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
spellingShingle |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review Botero, Beatriz Antidepressivos Crianças Adolescentes Fatores de risco e suicídio. Antidepresivos Niños Adolescentes Factores de riesgo y suicidio. Antidepressants Children Teenagers Risk factors and suicide. |
title_short |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
title_full |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
title_fullStr |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
title_full_unstemmed |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
title_sort |
Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review |
author |
Botero, Beatriz |
author_facet |
Botero, Beatriz Figueiredo, Erick Frota Gomes Costa, Jesus Eden Bezerra da Magalhães, Méllory Nétaly de Oliveira Almeida , Pablo Henrique Freitas de Martim, Salomão Rocha Silva, Ytalo Thiago Praciano da |
author_role |
author |
author2 |
Figueiredo, Erick Frota Gomes Costa, Jesus Eden Bezerra da Magalhães, Méllory Nétaly de Oliveira Almeida , Pablo Henrique Freitas de Martim, Salomão Rocha Silva, Ytalo Thiago Praciano da |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Botero, Beatriz Figueiredo, Erick Frota Gomes Costa, Jesus Eden Bezerra da Magalhães, Méllory Nétaly de Oliveira Almeida , Pablo Henrique Freitas de Martim, Salomão Rocha Silva, Ytalo Thiago Praciano da |
dc.subject.por.fl_str_mv |
Antidepressivos Crianças Adolescentes Fatores de risco e suicídio. Antidepresivos Niños Adolescentes Factores de riesgo y suicidio. Antidepressants Children Teenagers Risk factors and suicide. |
topic |
Antidepressivos Crianças Adolescentes Fatores de risco e suicídio. Antidepresivos Niños Adolescentes Factores de riesgo y suicidio. Antidepressants Children Teenagers Risk factors and suicide. |
description |
The transition from childhood to adolescence is a period of life characterized by hormonal and physiological changes. In this phase, there are also several social interactions that change according to the environment, imposing responsibilities and a desire for new cycles. These demands make people vulnerable and insecure to certain feelings, generating mood disorders that can progress to major depression disorder. Objective: to evaluate the efficacy and risks of psychotropic drugs prescribed to children and adolescents with depression disorders. Method: This is a bibliographic review of scientific articles of the descriptive-quantitative type, searched online, on Google Scholar platforms, Virtual Health Library - VHL (Medline, IBECS, LILACS), Portal Periodicals CAPES and SciELO and prepared from 1987 to 2021. The search used the descriptors, antidepressants, psychotropic drugs, adverse effects, depressed children and adolescents, in Portuguese, English and Spanish. Result: the same psychotropic drug is used in several other mental disorders, such as bipolar disorder and anxiety. Drugs that demonstrated significant efficacy were Serotonin Reuptake Inhibitors (SSRIs) such as paroxetine, sertraline and fluoxetine. Final Considerations: the psychotropic drugs used to treat depression in children and adolescents, although they are effective in some cases, nevertheless cause several adverse effects. The use of these drugs should not be carried out indiscriminately so that their risks do not outweigh their benefits, and it is essential to assess the causes of childhood depression and the clinical follow-up of patients by a multidisciplinary team. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/36284 10.33448/rsd-v11i14.36284 |
url |
https://rsdjournal.org/index.php/rsd/article/view/36284 |
identifier_str_mv |
10.33448/rsd-v11i14.36284 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/36284/30363 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 14; e304111436284 Research, Society and Development; Vol. 11 Núm. 14; e304111436284 Research, Society and Development; v. 11 n. 14; e304111436284 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052773459558400 |